Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.

George-Chandy A, Trysberg E, Eriksson K.

Arthritis Res Ther. 2008;10(4):R97. doi: 10.1186/ar2484. Epub 2008 Aug 22.

2.

Th17 development and autoimmune arthritis in the absence of reactive oxygen species.

George-Chandy A, Nordström I, Nygren E, Jonsson IM, Postigo J, Collins LV, Eriksson K.

Eur J Immunol. 2008 Apr;38(4):1118-26. doi: 10.1002/eji.200737348.

3.

Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells.

George Chandy A, Hultkrantz S, Raghavan S, Czerkinsky C, Lebens M, Telemo E, Holmgren J.

Immunology. 2006 Jul;118(3):311-20.

4.

Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.

Holmgren J, Adamsson J, Anjuère F, Clemens J, Czerkinsky C, Eriksson K, Flach CF, George-Chandy A, Harandi AM, Lebens M, Lehner T, Lindblad M, Nygren E, Raghavan S, Sanchez J, Stanford M, Sun JB, Svennerholm AM, Tengvall S.

Immunol Lett. 2005 Mar 15;97(2):181-8. Epub 2004 Dec 7. Review.

PMID:
15752556
5.

Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses.

Anjuère F, George-Chandy A, Audant F, Rousseau D, Holmgren J, Czerkinsky C.

J Immunol. 2003 Feb 1;170(3):1586-92.

6.

Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells.

George-Chandy A, Eriksson K, Lebens M, Nordström I, Schön E, Holmgren J.

Infect Immun. 2001 Sep;69(9):5716-25.

7.
8.

Mucosal immunity and tolerance: relevance to vaccine development.

Czerkinsky C, Anjuere F, McGhee JR, George-Chandy A, Holmgren J, Kieny MP, Fujiyashi K, Mestecky JF, Pierrefite-Carle V, Rask C, Sun JB.

Immunol Rev. 1999 Aug;170:197-222. Review.

PMID:
10566152
9.

Antigen presentation in the murine oral epithelium.

Eriksson K, Ahlfors E, George-Chandy A, Kaiserlian D, Czerkinsky C.

Immunology. 1996 May;88(1):147-52.

10.

Differential in vivo effects of a superantigen and an antibody targeted to the same T cell receptor. Activation-induced cell death vs passive macrophage-dependent deletion.

Gonzalo JA, Baixeras E, González-García A, George-Chandy A, Van Rooijen N, Martínez C, Kroemer G.

J Immunol. 1994 Feb 15;152(4):1597-608.

PMID:
8120373

Supplemental Content

Loading ...
Support Center